Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design - PubMed (original) (raw)
Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design
Rachel Urwin et al. Infect Immun. 2004 Oct.
Abstract
The bacterium Neisseria meningitidis is a major cause of meningitis and septicemia worldwide. Outer membrane proteins (OMPs) are candidates in the search for comprehensive meningococcal vaccines; however, the formulation of OMP vaccines is complicated by antigenic diversity, which is generated by high levels of genetic reassortment and strong positive selection in the meningococcal antigen genes. The genetic and antigenic diversity of three OMPs (FetA, PorA, and PorB) among a global collection of meningococcal isolates representative of the major hyperinvasive clonal complexes was determined. There was evidence for antigenic structuring among the three OMPs that could not be explained purely by descent. These observations violated the predictions of the clonal and epidemic clonal models of population structure but were in concordance with models of strain structure which propose that host immunity selects for nonoverlapping antigen combinations. The patterns of antigenic variant combinations suggested that an OMP-based vaccine with as few as six PorA and five FetA variant sequences could generate homologous immune responses against all 78 isolates examined.
Figures
FIG. 1.
Phylogenetic analysis of 78 hyperinvasive meningococci by using seven concatenated housekeeping gene sequences (3,284 bp) (A) and three concatenated antigen gene sequences (4,209 bp) (B). Each isolate is color coded according to clonal complex, as defined by MLST.
Similar articles
- Antigenic shift and increased incidence of meningococcal disease.
Harrison LH, Jolley KA, Shutt KA, Marsh JW, O'Leary M, Sanza LT, Maiden MC; Maryland Emerging Infections Program. Harrison LH, et al. J Infect Dis. 2006 May 1;193(9):1266-74. doi: 10.1086/501371. Epub 2006 Mar 28. J Infect Dis. 2006. PMID: 16586364 - Molecular techniques for the investigation of meningococcal disease epidemiology.
Maiden MC, Frosch M. Maiden MC, et al. Mol Biotechnol. 2001 Jun;18(2):119-34. doi: 10.1385/MB🔞2:119. Mol Biotechnol. 2001. PMID: 11471454 Review. - Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.
Russell JE, Urwin R, Gray SJ, Fox AJ, Feavers IM, Maiden MCJ. Russell JE, et al. Microbiology (Reading). 2008 Apr;154(Pt 4):1170-1177. doi: 10.1099/mic.0.2007/014761-0. Microbiology (Reading). 2008. PMID: 18375809 Free PMC article. - The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.
Climent Y, Urwin R, Yero D, Martinez I, Martín A, Sotolongo F, Maiden MC, Pajón R. Climent Y, et al. Infect Genet Evol. 2010 May;10(4):546-54. doi: 10.1016/j.meegid.2010.02.002. Epub 2010 Feb 13. Infect Genet Evol. 2010. PMID: 20156598 - Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
Bai X, Borrow R. Bai X, et al. Expert Rev Vaccines. 2010 Oct;9(10):1203-17. doi: 10.1586/erv.10.116. Expert Rev Vaccines. 2010. PMID: 20923270 Review.
Cited by
- Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
de Lemos APS, Sacchi CT, Gonçalves CR, Camargo CH, Andrade AL. de Lemos APS, et al. PLoS One. 2020 Dec 21;15(12):e0243375. doi: 10.1371/journal.pone.0243375. eCollection 2020. PLoS One. 2020. PMID: 33347452 Free PMC article. - Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections.
Poolman JT. Poolman JT. NPJ Vaccines. 2020 Sep 11;5:84. doi: 10.1038/s41541-020-00232-0. eCollection 2020. NPJ Vaccines. 2020. PMID: 32963814 Free PMC article. Review. - Diversification in immunogenicity genes caused by selective pressures in invasive meningococci.
Kremer PHC, Lees JA, Ferwerda B, Bijlsma MW, MacAlasdair N, van der Ende A, Brouwer MC, Bentley SD, van de Beek D. Kremer PHC, et al. Microb Genom. 2020 Sep;6(9):mgen000422. doi: 10.1099/mgen.0.000422. Epub 2020 Aug 10. Microb Genom. 2020. PMID: 32776867 Free PMC article. - Neisseria meningitidis: analysis of pili and LPS in emerging Brazilian strains.
Portilho AI, Trzewikoswki de Lima G, De Gaspari E. Portilho AI, et al. Ther Adv Vaccines Immunother. 2020 May 8;8:2515135520919195. doi: 10.1177/2515135520919195. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32435751 Free PMC article. - Molecular diagnostic techniques.
Kurkela S, Brown DWG. Kurkela S, et al. Medicine (Abingdon). 2009 Oct;37(10):535-540. doi: 10.1016/j.mpmed.2009.07.012. Epub 2009 Sep 19. Medicine (Abingdon). 2009. PMID: 32288568 Free PMC article. Review.
References
- Bjune, G., E. A. Høiby, J. K. Grønnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A. K. Lindbak, H. Nøkleby, E. Rosenqvist, L. K. Solberg, O. Closs, J. Eng, L. O. Frøholm, A. Lystad, L. S. Bakketeig, and B. Hareide. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources